LIPIN Pharmaceutical

Lipin Pharmaceutical is a biopharmaceutical company focused on the development of innovative drug delivery systems and complex formulations. The company utilizes its proprietary platforms, including Lipin-Film and Lipin-Sustained, to develop improved versions of existing medications via the 505(b)(2) regulatory pathway. Its product pipeline primarily targets therapeutic areas such as neurology, cardiovascular diseases, and pain management. Lipin aims to improve patient compliance and therapeutic outcomes through advanced oral thin films and sustained-release technologies. The company maintains research and manufacturing facilities in China and targets both domestic and international markets.